Karen A. Hartnett-Scott

Imprecision in Precision Medicine: Differential Response of a Disease-Linked GluN2A Mutant to NMDA Channel Blockers

E. Aizenman, J. Gale, Gabrielle J. Kosobucki, 2021, Frontiers in Pharmacology.

Defining the Kv2.1–syntaxin molecular interaction identifies a first-in-class small molecule neuroprotectant

C. Camacho, T. Tzounopoulos, R. Khanna, 2019, Proceedings of the National Academy of Sciences.

Molecular Neuroprotection Induced by Zinc-Dependent Expression of Hepatitis C–Derived Protein NS5A Targeting Kv2.1 Potassium Channels

M. Palladino, E. Aizenman, Gabrielle J. Kosobucki, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Copper induces neuron‐sparing, ferredoxin 1‐independent astrocyte toxicity mediated by oxidative stress

P. Rosenberg, E. Aizenman, J. Gale, 2023, Journal of neurochemistry.

The expression system influences stability, maturation efficiency, and oligomeric properties of the potassium-chloride co-transporter KCC2

Karen A. Hartnett-Scott, J. L. Brodsky, Elias Aizenman, 2024, Neurochemistry International.